Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rang in aandelen #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Aandeelprijs
$0.78404857
Marktkapitalisatie
$36.98M
Verandering (1 dag)
-1.49%
Verandering (1 jaar)
139.26%
Land
FR
Handel Theraclion SA (ALTHE)

Categorie

P/B-ratio voor Theraclion SA (ALTHE)
P/B-ratio op July 2026 TTM: -14.11
Volgens de meest recente financiële rapporten en aandelenkoers van Theraclion SA is de huidige P/B-ratio (TTM) -14.11. Eind 2023 had het bedrijf een P/B-ratio van 3.14.
P/B-ratiohistoriek voor Theraclion SA van 2010 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) -14.11 -99.99%
2024 -133.83K -4,259,251.68%
2023 3.14 -93.56%
2022 48.76 -308.04%
2021 -23.44 132.26%
2020 -10.09 -96.80%
2019 -315.54 2,868.09%
2018 -10.63 -221.88%
2017 8.72 44.54%
2016 6.03 -82.25%
2015 34.00 228.35%
2014 10.36 -210.01%
2013 -9.41 -107.46%
2012 126.12 -59.55%
2011 311.80 959.96%
2010 29.42 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.0429 -121.56%
US
5.2455 -137.17%
US
2.0273 -114.37%
IE
2.4503 -117.36%
US
5.0733 -135.95%
US